Vanguard Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.47B Sell
8,701,472
-94,728
-1% -$29.6M 0.04% 431
2025
Q3
$2.72B Buy
8,796,200
+87,845
+1% +$27.5M 0.04% 408
2025
Q2
$2.74B Buy
8,708,355
+39,403
+0.5% +$11.4M 0.04% 389
2025
Q1
$2.28B Buy
8,668,952
+178,976
+2% +$48.4M 0.04% 420
2024
Q4
$2.22B Buy
8,489,976
+16,095
+0.2% +$4.05M 0.04% 432
2024
Q3
$1.97B Buy
8,473,881
+73,855
+0.9% +$15.2M 0.04% 466
2024
Q2
$1.7B Buy
8,400,026
+200,912
+2% +$36.2M 0.03% 481
2024
Q1
$1.41B Buy
8,199,114
+169,506
+2% +$31.6M 0.03% 552
2023
Q4
$1.74B Buy
8,029,608
+29,387
+0.4% +$5.04M 0.04% 463
2023
Q3
$1.28B Buy
8,000,221
+18,282
+0.2% +$4.09M 0.03% 522
2023
Q2
$2.3B Buy
7,981,939
+78,535
+1% +$23.9M 0.05% 362
2023
Q1
$2.52B Buy
7,903,404
+1,375,149
+21% +$408M 0.06% 331
2022
Q4
$1.92B Buy
6,528,255
+135,634
+2% +$37.4M 0.05% 392
2022
Q3
$1.47B Buy
6,392,621
+64,742
+1% +$16.2M 0.04% 437
2022
Q2
$1.38B Buy
6,327,879
+123,938
+2% +$28.2M 0.04% 480
2022
Q1
$1.65B Buy
6,203,941
+58,932
+1% +$14.5M 0.04% 494
2021
Q4
$1.64B Buy
6,145,009
+24,707
+0.4% +$7.17M 0.04% 496
2021
Q3
$1.74B Buy
6,120,302
+216,648
+4% +$61.8M 0.04% 461
2021
Q2
$1.62B Buy
5,903,654
+14,559
+0.2% +$3.96M 0.04% 485
2021
Q1
$1.54B Buy
5,889,095
+7,281
+0.1% +$1.95M 0.04% 475
2020
Q4
$1.5B Buy
5,881,814
+120,032
+2% +$29.8M 0.04% 452
2020
Q3
$1.36B Sell
5,761,782
-192,371
-3% -$40.5M 0.05% 423
2020
Q2
$1.16B Buy
5,954,153
+231,511
+4% +$44.3M 0.04% 456
2020
Q1
$948M Buy
5,722,642
+144,606
+3% +$26.4M 0.04% 455
2019
Q4
$955M Buy
5,578,036
+187,522
+3% +$31.2M 0.03% 552
2019
Q3
$889M Buy
5,390,514
+106,225
+2% +$14.9M 0.03% 552
2019
Q2
$631M Buy
5,284,289
+24,197
+0.5% +$2.48M 0.02% 692
2019
Q1
$500M Buy
5,260,092
+70,940
+1% +$6.08M 0.02% 780
2018
Q4
$412M Buy
5,189,152
+135,495
+3% +$11.5M 0.02% 800
2018
Q3
$535M Buy
5,053,657
+84,209
+2% +$7.88M 0.02% 766
2018
Q2
$426M Buy
4,969,448
+7,332
+0.1% +$658K 0.02% 857
2018
Q1
$430M Buy
4,962,116
+133,970
+3% +$10.4M 0.02% 826
2017
Q4
$333M Buy
4,828,146
+79,064
+2% +$5.19M 0.01% 963
2017
Q3
$262M Buy
4,749,082
+93,963
+2% +$5.13M 0.01% 1082
2017
Q2
$239M Buy
4,655,119
+98,272
+2% +$4.27M 0.01% 1112
2017
Q1
$196M Buy
4,556,847
+184,465
+4% +$7.91M 0.01% 1232
2016
Q4
$165M Buy
4,372,382
+124,149
+3% +$4.62M 0.01% 1295
2016
Q3
$174M Buy
4,248,233
+63,253
+2% +$2.5M 0.01% 1211
2016
Q2
$127M Buy
4,184,980
+124,551
+3% +$3.87M 0.01% 1345
2016
Q1
$135M Buy
4,060,429
+113,087
+3% +$3.55M 0.01% 1269
2015
Q4
$149M Buy
3,947,342
+77,539
+2% +$2.61M 0.01% 1184
2015
Q3
$100M Buy
3,869,803
+107,274
+3% +$3.25M 0.01% 1420
2015
Q2
$117M Buy
3,762,529
+135,263
+4% +$3.99M 0.01% 1418
2015
Q1
$121M Buy
3,627,266
+182,960
+5% +$6.18M 0.01% 1366
2014
Q4
$159M Buy
3,444,306
+45,048
+1% +$1.93M 0.01% 1111
2014
Q3
$125M Buy
3,399,258
+47,197
+1% +$1.72M 0.01% 1206
2014
Q2
$133M Buy
3,352,061
+7,386
+0.2% +$284K 0.01% 1212
2014
Q1
$159M Buy
3,344,675
+150,090
+5% +$6.64M 0.01% 1054
2013
Q4
$119M Buy
3,194,585
+225,040
+8% +$8.31M 0.01% 1207
2013
Q3
$108M Buy
2,969,545
+116,668
+4% +$3.92M 0.01% 1193
2013
Q2
$89.6M Buy
+2,852,877
New +$80.8M 0.01% 1239

Other funds holding PODD

Vanguard Group's PODD Position: Q4 2025 in Review

Vanguard Group reduced its Insulet (PODD) stake by 1.1% in Q4 2025, selling an estimated $29.6M and leaving 8,701,472 shares worth $2.47B. The position accounts for 0.04% of the portfolio, ranked #431.

Vanguard Group first reported a position in PODD in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.74B in Q2 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • Vanguard Group held 8,701,472 shares of Insulet worth $2.47B as of Q4 2025.
  • Vanguard Group sold 94,728 Insulet shares in Q4 2025, an estimated $29.6M.
  • Insulet made up 0.04% of Vanguard Group's portfolio in Q4 2025, its #431 holding.
  • Vanguard Group first reported a position in Insulet in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Insulet position peaked at $2.74B in Q2 2025.
  • 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.